HEREDITARY CANCER
Hereditary Cancer (HC) testing is a simple saliva sample analyzed to determine if mutations are present in a patient. HC Testing is a preventative to not a diagnosis of cancer. We accept Medicare patients who have had HC or a family history of HC.
6. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastro. 2010 Jun;138(6):2044-58.
7. Burt RW, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastro. 2004 Aug;127(2):444-51.
5. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643-6.
9. Moyer VA on behalf of the U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Feb 18;160(4):271-81.
Our test analyzes the most relevant genes for mutations that could increase patient's risk for:
BREAST CANCER
PROSTATE CANCER
UTERINE CANCER
COLON CANCER
PANCREATIC CANCER
STOMACH CANCER
PharmacoGenomic (PGx) testing is a simple cheek swab can reveal which medications may cause side effects or even dangerous adverse reactions.Finding the medication that works best for you shouldn’t be a guessing game. Traditional medicine employs a trial and error approach, but pharmacogenetic testing offers specific guidance about medications that work best for you based on your DNA.
PHARMACOGENOMICS
The RIGHT DOSE, of the RIGHT DRUG, to the RIGHT PATIENT, at the RIGHT TIME.
Medication is not working.
WHY?
Unwanted side effects.
Taking multiple medications.
Personal information on biomarkers.